Search

for
Search:

Glossary Setipiprant

Setipiprant is an investigational oral medication that acts as a selective antagonist of the prostaglandin D2 receptor (DP2), which is implicated in hair loss, particularly androgenetic alopecia. By blocking this receptor, setipiprant aims to inhibit the signaling pathways that contribute to hair follicle miniaturization and hair thinning. Its relevance lies in its potential to promote hair regrowth and improve hair density in individuals experiencing hair loss, distinguishing it from other treatments that may target different biological mechanisms. Ongoing clinical trials are assessing its efficacy and safety in the context of hair restoration.

Related Terms

Learn

1 / 800 results

learn Setipiprant

What is Setipiprant and how does it differ from DHT blockers like finasteride or dutasteride? Setipiprant blocks the prostaglandin D2 receptor DP2 rather than the DHT pathway that finasteride and dutasteride act on. The one published human trial — a 169-man, 24-week phase 2a study at 2,000 mg a day — reported no statistically significant improvement in hair density over placebo, and setipiprant is not an approved hair-loss medicine anywhere.
How does Setipiprant work on the scalp to potentially promote hair regrowth? Setipiprant blocks the DP2 (CRTH2) receptor that prostaglandin D₂ acts through, and PGD₂ is reported to be elevated in balding scalp — but the one published placebo-controlled trial in men (DuBois 2021, n=169) found no significant hair regrowth. It is an experimental compound, not an approved hair-loss medicine.
Is Setipiprant taken orally or applied topically, and what do studies show about its results? Every published human study of setipiprant used oral tablets; no peer-reviewed trial has tested a topical version. Results were inconsistent in seasonal allergic rhinitis, and the one controlled hair-loss trial (DuBois 2021, 169 men, 24 weeks) found no significant regrowth. It is an experimental, unapproved compound.
All 5 questions on Setipiprant →

View more "Setipiprant" in learn →

Research

5 / 46 results

research Does Inhibition of Aldose Reductase Contribute to the Anti-Inflammatory Action of Setipiprant?

6 citations , August 2017 in “Physiological Research”

This study suggests that setipiprant's inhibitory effect on aldose reductase may contribute to its anti-inflammatory properties, adding a possible mechanism beyond its known action on the prostaglandin D2 receptor.

research Verification of the Major Metabolic Oxidation Path for the Naphthoyl Group in Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTh2) Antagonist 2-(2-(1-Naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic Acid (Setipiprant/ACT-129968)

6 citations , September 2015 in “Journal of Medicinal Chemistry”

This study synthesized and verified the structures of Setipiprant's major and minor metabolites, confirming their regio- and enantioselectivity from earlier proposals in a clinical study.

research Setipiprant for Androgenetic Alopecia in Males: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 2a Trial

3 citations , October 2021 in “Clinical, Cosmetic and Investigational Dermatology”

This study found that oral setipiprant was safe but did not improve scalp hair growth compared to placebo in men with androgenetic alopecia.

research A bald statement - Current approaches to manipulate miniaturisation focus only on promoting hair growth

30 citations , May 2018 in “Experimental Dermatology”

This article reviews the cellular dynamics affecting dermal papilla size in androgenetic alopecia and suggests targeting DP size could improve therapies, but it presents no new clinical data.

research New drugs under investigation for the treatment of alopecias

26 citations , January 2019 in “Expert Opinion on Investigational Drugs”

This review explored the new and emerging treatments for androgenetic alopecia and alopecia areata, finding that JAK inhibitors show promise for alopecia areata, while advancements in stem-cell research may eventually lead to new and improved treatments for androgenetic alopecia.

View more "Setipiprant" in research →

Community Join

5 / 26 results

community Setipiprant/PGE2 feedbacks?

4 upvotes 8 years ago

The conversation discusses using PGE2 as a hair growth stimulant, comparing it to minoxidil, and considering the addition of Setipiprant. Concerns about side effects like skin damage and cost are also mentioned.

community In theory, will everyone on setipiprant be able to maintain their hair forever?

4 upvotes 10 years ago

Setipiprant may help with hair maintenance but is not a guaranteed solution for everyone. Other treatments like minoxidil, finasteride, and topical spironolactone are discussed, with varying opinions on their effectiveness.

community Updates on setipiprant, bimatoprost?

4 upvotes 11 years ago

Setipiprant and bimatoprost are being discussed as potential future treatments for hair loss. Some individuals have started testing setipiprant before FDA approval, but no progress updates are available yet.

community Where to buy setipiprant from ?

2 upvotes 1 year ago

The conversation is about hair loss treatments, specifically setipiprant, which the user is considering after experiencing side effects from finasteride and dutasteride. Another user mentions that setipiprant was ineffective in clinical trials.

community Thinking about signing up for the setipiprant clinical trials

5 upvotes 9 years ago

The conversation discusses hair loss treatments, with the original poster considering joining a clinical trial for setipiprant after experiencing side effects from finasteride and disinterest in minoxidil. Some users express skepticism about setipiprant's effectiveness, while others encourage participation in the trial for potential benefits.

View more "Setipiprant" in community →

Experts

— no results

Try a deeper search in experts →

Clinics

— no results

Try a deeper search in clinics →